RadTran

Centennial, United States Founded: 2012 • Age: 14 yrs Acquired By Energy Fuels
Manufacturer of cancer drugs

About RadTran

RadTran is a Healthcare company based in Centennial (United States) founded in 2012 by Saleem Drera, and was acquired by Energy Fuels in August 2024. Manufacturer of cancer drugs. Its chief executive, as recorded, is Saleem Drera. RadTran offers products and services including Ra-224 Isotopes and Ac-225 Isotopes. Its focus areas include Traditional Pharmaceuticals. Its legal entity is RadTran LLC.

Company details

RadTran, established in 2012 and currently in Acquired stage, focuses on providing healthcare solutions, and traditional pharmaceuticals. Manufacturer of cancer drugs. Adapting to market demands with innovation and client-focused strategies. It continues to evolve, meeting industry challenges with strategic approaches.

  • Headquarters Centennial, United States
  • Founders Saleem Drera
  • Stage Acquired
  • Sectors
    Healthcare
  • Website radtran.com
  • Social LinkedIn
  • Acquired by Energy Fuels (Aug 2024)
  • Legal Name Radtran Llc
Key Metrics

Products & Services of RadTran

RadTran offers a comprehensive portfolio of products and services, including Ra-224 Isotopes and Ac-225 Isotopes.

Ra-224 Isotopes
Medical Isotopes

Ra-224 isotopes are produced for targeted alpha therapies in cancer treatment, where extraction from Thorium-232 is performed to meet pharmaceutical needs.

Ac-225 Isotopes
Radioactive Materials

Ac-225 isotopes are supplied for therapeutic applications, where production methods are developed to overcome supply limitations and high costs.

Funding Insights of RadTran

  • Total Rounds 2
  • Last Round Grant β€” $355,000
  • First Round $194,500

    (Feb 2020)

  • Investors Count 1

All 2 funding rounds of RadTran with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2021$355,000Grant––
Feb 2020$194,500Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in RadTran

RadTran has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Energy Fuels and OSTI.GOV.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Scientific and technical information is managed and disseminated by OSTI.GOV.
osti.govOak Ridge, United States
Uranium and vanadium exploration and development services are provided.
2006energyfuels.comLakewood, United States
Premium access

Investor details for RadTran

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of RadTran

1 people are tracked at RadTran (1 in leadership).

NameRoleGroup
Saleem Drera
Founder & CEOLeadership
Premium access

Complete people profiles for RadTran

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of RadTran

4 dated milestones of RadTran across 12 years, from founding to its latest funding, stage changes and deals.

  1. Founded RadTran is founded.
  2. Funding First funding round of $194K.
  3. Funding Latest funding round, Grant, of $355K.
  4. Exit Acquired by Energy Fuels.

Top companies in Traditional Health & Nutrition

3 companies that operate in the same segment as RadTran (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Manufacturer of generics formulations
2002Bridgewater, New Jersey, United StatesUSD 3.02 B8,300
Biosimilar therapeutics are developed for oncology and autoimmune diseases.
2010Redwood City, California, United StatesUSD 143.62 MUSD 42.17 M228
Ophthalmic pharmaceuticals and instruments are developed for eye care.
1853Bridgewater, New Jersey, United StatesUSD 5.1 B13,500
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about RadTran

RadTran was founded in 2012 and raised its 1st funding round 8 years after it was founded.

RadTran is headquartered in Centennial, United States. It is registered at Centennial, Colorado, United States.

Saleem Drera is the CEO of RadTran, as recorded in our data. They have also founded this company.

RadTran, established in 2012 and currently in Acquired stage, focuses on providing healthcare solutions, and traditional pharmaceuticals. Manufacturer of cancer drugs. Adapting to market demands with innovation and client-focused strategies. It continues to evolve, meeting industry challenges with strategic approaches.

RadTran offers Ra-224 Isotopes and Ac-225 Isotopes.

RadTran has 2 investors. Key investors include Energy Fuels, and OSTI.GOV.

RadTran operates through Radtran Llc.

Yes. RadTran was acquired by Energy Fuels in August 2024.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available